Developing tests to detect and identify infectious bacteria.
Official title: Task Area E: NIAID Preclinical Services for AMR Diagnostics Development
Funded at Resourcepath, LLC · NIH-10913856 · Data updated 2026-11-12
This study is working on better tests to quickly and accurately find harmful bacteria in people, helping doctors give the right treatment for infections and tackle the issue of bacteria that resist medicine.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Resourcepath, LLC NIH-funded |
| Lab location | 1 site (Sterling, United States) |
| Project start | June 20, 2023 |
| Project end | June 19, 2030 |
| Funding year | 2023 |
| Award (this year) | $3,500 |
| NIH project number | 75N93023D00018-0-759302300001-1 |
| Project ID | NIH-10913856 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing symptoms of bacterial infections or those at risk of such infections.
✕Less likely to help
Patients with viral infections or those not affected by bacterial pathogens may not receive any benefit from this research.
What this research studies
This research focuses on creating and improving diagnostic tests that can accurately detect and identify various infectious bacteria in humans. By utilizing advanced biological assays, the project aims to enhance the understanding of bacterial drug resistance, which is a growing concern in healthcare. Patients may benefit from more effective diagnostics that can lead to timely and appropriate treatments for bacterial infections. The research involves collaboration with various stakeholders to ensure that the developed assays meet clinical needs.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely diagnoses of bacterial infections, improving treatment outcomes for patients.
How similar studies have gone: Other research has shown success in developing diagnostic tests for bacterial infections, indicating that this approach has potential for meaningful advancements.
Where this research is happening
-
Resourcepath, LLC
Sterling, United States Active
Researchers
- Principal investigator: Hill, Dana Ashley — Resourcepath, LLC
- Study coordinator: Hill, Dana Ashley
Related research
Other NIH-funded projects on the same topics.
-
Creating tests to detect the SARS-CoV-2 virus
This study is working on new tests to quickly and accurately detect the COVID-19 virus in people, helping ensure that patients get the right treatment when they need it.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.